Platelet and leukocyte activation during aortoiliac angiography and angioplasty

European Journal of Vascular and Endovascular Surgery

Volumn 23, Issue 3, 2002, Pages 220-225

  Barani, J ^a   Gottsater A ^a   Mattiasson, I ^a   Lindblad, B ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

cAMP; CD18; cGMP; Flow cytometry; P selectin

Indexed keywords

CD18 ANTIGEN; CONTRAST MEDIUM; CYCLIC AMP; CYCLIC GMP; FIBRINOGEN; IOHEXOL; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; NEOPTERIN; PADGEM PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BODY MASS; CLINICAL ARTICLE; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; AORTA; AORTOGRAPHY; ARTERIOSCLEROSIS; DRUG EFFECT; ILIAC ARTERY; LEUKOCYTE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RADIOGRAPHY;

AGED; AGED, 80 AND OVER; ANGIOGRAPHY; ANGIOPLASTY, BALLOON; AORTA; AORTOGRAPHY; ARTERIOSCLEROSIS; CONTRAST MEDIA; FEMALE; HUMANS; ILIAC ARTERY; LEUKOCYTES; MALE; MIDDLE AGED; PLATELET ACTIVATION;

EID: 0036515072     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1053/ejvs.2001.1594     Document Type: Article

References (36)

1. STEELE P, CHESEBRO J, STANSON A et al. Balloon angioplasty: natural history of the pathophysiological response to injury in a pig model. Circ Res 1985; 57: 105-112.
2. WILCOX J, SMITH K, SCHWARTZ S, GORDON D. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque. Proc Natl Acad Sci USA 1986; 134: 1087-1097.
3. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med 1999; 340: 115-126.
4. HARKER L. Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. Am J Cardiol 1987; 60: 20B-28B.
5. SAREMBOCK I, LAVEAU P, SIGAL S et al. Influence of inflation pressure and balloon size on the development of intimal hyperplasia after balloon angioplasty: a study in the atherosclerotic rabbit. Circulation 1989; 80: 1029-1040.
6. GASPERETTI C, GONIAS S, GIMPLE L, POWERS E. Platelet activation during coronary angioplasty in humans. Circulation 1993; 88: 2728-2734.
7. LAFFAN M, DAWSON P, GOODING RP. A comparison between the platelet activating properties of different contrast media used in radiology and MRI. Br J Radiol 1997; 70: 798-804.
8. HAMBURGER S, MCEVER R. GMP-140 mediates adhesion of stimulated platelet to neutrophils. Blood 1990; 75: 550-554.
9. WARZOK F, STEINER M, BLANN AD et al. Immediate and late effects of coronary angiography on soluble endothelial cell markers and P-selectin in patients with and without coronary artery disease. Blood Coagul Fibrinol 1999; 10: 381-387.
10. FURMAN M, BENOIT S, BARNARD M et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31: 352-358.
11. MICKELSON J, LAKKIS N, VILLARREALLEVY G, HUGHES B, SMITH C. Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease? J Am Coll Cardiol 1996; 28: 345-353.
12. NEUMANN F, OTT I, GAWAZ M, PUCHNER G, SCHÖMIG A. Neutrophil and platelet activation at balloon-injured coronary artery plaque in patients undergoing angioplasty. J Am Coll Cardiol 1996; 27: 819-824.
13. NEUMANN F-J, RICHARDT G, SCHNEIDER M et al. Cardiac release of chemoattractants after ischaemia induced by coronary balloon angioplasty. Br Heart J 1993; 70: 27-34.
14. DESERVI S, MAZZONE A, RICEVUTI G et al. Granulocyte activation after coronary angioplasty in humans. Circulation 1990; 82: 140-146.
15. MAZZONE A, DESERVI S, RICEVUTI G et al. Increased expression of neutrophil and monocyte adhesion molecules in unstable coronary artery disease. Circulation 1993; 88: 358-363.
16. DESERVI S, MAZZONE A, RICEVUTI G et al. Clinical and angiographic correlates of leukocyte activation in unstable angina. J Am Coll Cardiol 1995; 26: 1146-1150.
17. DANIELSSON P, SCHATZ P, SWARTBOL P et al. Response of inflammatory markers to balloon angioplasty in peripheral arterial occlusive disease. Eur J Vasc Endovasc Surg 2000; 20: 550-555, doi:10.1053/ejvs.2000.1244.
18. INOUE T, SAKAI Y, FUJITO T et al. Clinical significance of neutrophil adhesion molecules expression after coronary angioplasty on the development of restenosis. Thromb Haemost 1998; 79: 54-58.
19. SERRANO CV, RAMIRES JA, VENTURINELLI M et al. Coronary angioplasty results in leukocyte and platelet activation with adhesion molecule expression. Evidence of inflammatory responses in coronary angioplasty. J Am Coll Cardiol 1997; 29: 1276-1283.
20. TSCHOEPE D, SCHULTHEISS HP, KOLAROV P et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993; 88: 37-42.
21. WARE J, HEISTAD D. Platelet-endothelium interactions. N Engl J Med 1993; 328: 628-635.
22. MONCADA S, HIGGS A. The L-arginine-nitric oxide pathway. N Engl J Med 1993; 329: 2002-2012.
23. KREMASTINOS DT, ILIODROMITIS EK, MARKIANOS M et al. Intracoronary cyclic-GMP and cyclic-AMP during percutaneous transluminal coronary angioplasty. Int J Cardiol 1996; 53: 227-232.
24. KISHIMOTO T. The biology of Interleukin 6. Blood 1989; 74: 1-10.
25. AGGARWAL BB, KOHR WJ, HASS PE et al. Human tumor necrosis factor. Production, purification and characterization. J Biol Chem 1985; 260: 2345-2354.
26. KOJIMA S, ICHO T, KAJIWARA Y, KUBOTA K. Neopterin as an endogenous antioxidant. FEBS letters 1992; 304: 163-166.
27. TATZBER F, RABL H, KORISKA K et al. Elevated serum neopterin levels in atherosclerosis. Atherosclerosis 1991; 89: 203-208.
28. FUCHS D, HAUSEN A, REIBNEGGER G et al. Neopterin as a marker for cell-mediated immunity. Immunol Today 1988; 9: 150-155.
29. HUBER C, BATCHELOR J, FUCHS D et al. Immune-response associated production of neopterin. Release from macrophages primarily under control of interferon gamma. J Exp Med 1984; 160: 310-316.
30. WIEDERMANN C, BEIMPOLD H, HEROLD M, KNAPP E, BRAUNSTEINER H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol 1993; 22: 1897-1901.
31. GROSS S, LEVI R. Tetrahydrobiopterin synthesis. An absolute requirement for cytokine-induced nitric oxide generation by vascular smooth muscle. J Biol Chem 1992; 267: 25722-25729.
32. SAKAI N, KAUFMAN S, MILSTEIN S. Tetrahydrobiopterin is required for cytokine-induced nitric oxide production in a murine macrophage cell line. Mol Pharmacol 1993; 43: 6-10.
33. BURSTEIN M, SCHOLNIK H, MORFIN R. Rapid method for the isolation of proteins from human serum by precipitation with polyanions. J Lipid Res 1970; 11: 583-595.
34. ANWAAR I, GOTTSÄTER A, OHLSSON K, MATTIASSON I, LINDGÄRDE F. Increasing levels of leukocyte derived inflammatory mediators in plasma and cAMP in platelets during follow-up after acute cerebral ischaemia. Cerebrovasc Dis 1998; 8: 310-317.
35. WATANABE H, KAKIHANA M, OHTSUKA S et al. Platelet cyclic GMP. A potentially useful indicator to evaluate the effects of nitroglycerin and nitrate tolerance. Circulation 1993; 88: 29-36.
36. BLANN AD, ADAMS RA, KATAI F, ASHLEIGH R, TABERNER DA. Haematology and coagulation indices in paired samples of arterial and venous blood from patients with arterial disease. Haemostasis 1996; 26: 72-78.